Cost-Effectiveness of the Freeze-All Policy

Matheus Roque1, Marcello Valle1, Fernando Guimarães1

  • 1ORIGEN - Center for Reproductive Medicine, Rio de Janeiro/RJ - Brazil.

Insights

Freeze-all cycles are more cost-effective than fresh embryo transfers, offering a higher pregnancy rate and lower overall treatment costs. This strategy improves outcomes in assisted reproductive technology.

Area of Science:

  • Reproductive Endocrinology
  • Health Economics
  • In Vitro Fertilization (IVF)

Background:

  • Fresh embryo transfer has been the standard in IVF.
  • Concerns exist regarding the impact of ovarian stimulation on the endometrium for fresh transfer.
  • Freeze-all cycles offer a potential alternative for optimizing implantation rates.

Purpose of the Study:

  • To compare the cost-effectiveness of freeze-all cycles versus fresh embryo transfer.
  • To analyze pregnancy rates and treatment costs associated with each strategy.

Main Methods:

  • Observational study with cost-effectiveness analysis of 530 intracytoplasmic sperm injection (ICSI) cycles.
  • Compared 351 fresh embryo transfers with 179 freeze-all cycles using a GnRH antagonist protocol.
  • Two cost-effectiveness scenarios were analyzed, including all associated treatment expenses.

Main Results:

  • The freeze-all group demonstrated a higher pregnancy rate (39.7%) compared to the fresh group (31.1%).
  • Cost per pregnancy was significantly lower in freeze-all cycles ($19,156.73) versus fresh cycles ($23,059.72).
  • Even when accounting for all cryopreservation and frozen-thawed embryo transfer costs, freeze-all remained more cost-effective.

Conclusions:

  • A freeze-all policy is a more cost-effective strategy than fresh embryo transfer.
  • This approach enhances the economic viability of assisted reproductive technologies.
  • Freeze-all cycles represent an efficient strategy for improving IVF outcomes.
Abstract